US tariffs on medical imports drive rise in outbound medical tourism, India could benefit
Rising US tariffs on Chinese medical imports are inflating healthcare costs, prompting a surge in outbound medical tourism. Patients are increasingly choosing affordable treatment in countries like India and Mexico as domestic procedures grow costlier due to disrupted supply chains
New Delhi:As medical expenses continue to climb in the US, a growing number of patients are looking overseas for more cost-effective treatment options and suggested tariffs may impact the medical tourism industry, according to a new report.
US trade policy has seen notable changes recently, particularly with regard to import tariffs on countries such as China.
Though these policies are usually justified by economic and geopolitical considerations, they also impact other areas, including the medical device industry and, more specifically, medical tourism.
One growing outcome is how these tariffs are affecting medical tourism — the practice of traveling to another country to receive healthcare services, according to GlobalData, a leading data and analytics company.
The US has imposed steep tariffs on a range of medical products imported from China, including syringes and needles, rubber medical and surgical gloves, and facemasks.
“These items are integral to a wide variety of medical procedures and daily healthcare operations. The imposition of tariffs on such goods has disrupted supply chains, constrained hospital procurement strategies, and driven up the cost of healthcare delivery across the US,” said the report.
In response to these rising costs, a growing number of Americans are turning to medical tourism. Popular destinations include Mexico, India, Thailand, and Costa Rica, which offer competitive pricing and internationally accredited healthcare facilities.
For example, the average cost of a knee replacement surgery in the US can exceed $50,000, but the same procedure in India or Mexico can be performed for $8000-$12,000.
As US healthcare providers face increased operational costs due to tariffs – especially on imported surgical instruments, diagnostic equipment, and protective gear – the price gap between domestic and international care continues to widen, creating a financial incentive for patients to consider treatment overseas.
“While the intended impact of tariffs may not have been to effect healthcare, they do shape patient behaviour. The rise in the cost of medical devices ultimately leads to more out-of-pocket expenses for patients,” said Alexandra Murdoch, Senior Medical Analyst at GlobalData.
US tariffs on medical imports are reshaping not only international trade relationships but also domestic healthcare economics. The direct result is an increase in the cost of medical care, which disproportionately affects uninsured and underinsured populations.
One of the most notable responses to these price pressures has been a rise in outbound medical tourism. Patients are seeking high-quality, affordable care in countries that are not impacted by these tariffs — a trend that is likely to continue if current trade and healthcare cost trajectories remain unchanged.
